Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Day or overnight transfusion in critically ill patients: does it matter?

Aubron C, Kandane-Rathnayake RK, Andrianopoulos N, Westbrook A, Engelbrecht S, Ozolins I, Bailey M, Murray L, Cooper DJ, Wood EM, McQuilten ZK; Blood Observational Study investigators; ANZICS Clinical Trials Group.

Vox Sang. 2018 Apr;113(3):275-282. doi: 10.1111/vox.12635. Epub 2018 Feb 2.

PMID:
29392786
2.

Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, Billot L, Correa M, Glass P, Harward M, Joyce C, Li Q, McArthur C, Perner A, Rhodes A, Thompson K, Webb S, Myburgh J; ADRENAL Trial Investigators and the Australian–New Zealand Intensive Care Society Clinical Trials Group.

N Engl J Med. 2018 Mar 1;378(9):797-808. doi: 10.1056/NEJMoa1705835. Epub 2018 Jan 19.

PMID:
29347874
3.

Statistical analysis plan for the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) trial.

Billot L, Venkatesh B, Myburgh J, Finfer S, Cohen J, Webb S, McArthur C, Joyce C, Bellomo R, Rhodes A, Perner A, Arabi Y, Rajbhandari D, Glass P, Thompson K, Correa M, Harward M.

Crit Care Resusc. 2017 Jun;19(2):183-191.

PMID:
28651515
4.

Potential Impact of the 2016 Consensus Definitions of Sepsis and Septic Shock on Future Sepsis Research.

Peake SL, Delaney A, Bailey M, Bellomo R; ARISE Investigators.

Ann Emerg Med. 2017 Oct;70(4):553-561.e1. doi: 10.1016/j.annemergmed.2017.04.007.

PMID:
28601273
5.

Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis.

PRISM Investigators, Rowan KM, Angus DC, Bailey M, Barnato AE, Bellomo R, Canter RR, Coats TJ, Delaney A, Gimbel E, Grieve RD, Harrison DA, Higgins AM, Howe B, Huang DT, Kellum JA, Mouncey PR, Music E, Peake SL, Pike F, Reade MC, Sadique MZ, Singer M, Yealy DM.

N Engl J Med. 2017 Jun 8;376(23):2223-2234. doi: 10.1056/NEJMoa1701380. Epub 2017 Mar 21.

6.

The Australian and New Zealand Intensive Care Society Clinical Trials Group point prevalence program, 2009-2016.

Thompson K, Hammond N, Eastwood G, Festa M, Glass P, Rajbhandari D, Seppelt I, Taylor C, Watts N, Myburgh J; The Point Prevalence Program Management Committee ; The Australian and New Zealand Intensive Care Society Clinical Trials Group ; The George Institute for Global Health .

Crit Care Resusc. 2017 Mar;19(1):88-93.

PMID:
28215137
7.

Epidemiology of RBC Transfusions in Patients With Severe Acute Kidney Injury: Analysis From the Randomized Evaluation of Normal Versus Augmented Level Study.

Bellomo R, Mårtensson J, Kaukonen KM, Lo S, Gallagher M, Cass A, Myburgh J, Finfer S; Randomized Evaluation of Normal Versus Augmented Level of Replacement Therapy Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Med. 2016 May;44(5):892-900. doi: 10.1097/CCM.0000000000001518.

PMID:
26619086
8.

Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose.

Bellomo R, Mårtensson J, Lo S, Kaukonen KM, Cass A, Gallagher M; RENAL study investigators; Australian and New Zealand Intensive Care Clinical Trials Group.

Blood Purif. 2016;41(1-3):11-7. doi: 10.1159/000439581. Epub 2015 Oct 20.

9.

Acetaminophen for Fever in Critically Ill Patients with Suspected Infection.

Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, Holliday M, Henderson S, Mackle D, McArthur C, McGuinness S, Myburgh J, Weatherall M, Webb S, Beasley R; HEAT Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.

N Engl J Med. 2015 Dec 3;373(23):2215-24. doi: 10.1056/NEJMoa1508375. Epub 2015 Oct 5.

10.

A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.

Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R.

Crit Care Med. 2015 Aug;43(8):1622-9. doi: 10.1097/CCM.0000000000001004.

PMID:
25853591
11.

Goal-directed resuscitation for patients with early septic shock.

ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P.

N Engl J Med. 2014 Oct 16;371(16):1496-506. doi: 10.1056/NEJMoa1404380. Epub 2014 Oct 1.

12.

Traditional landmark versus ultrasound guided tracheal puncture during percutaneous dilatational tracheostomy in adult intensive care patients: a randomised controlled trial.

Rudas M, Seppelt I, Herkes R, Hislop R, Rajbhandari D, Weisbrodt L.

Crit Care. 2014 Sep 18;18(5):514. doi: 10.1186/s13054-014-0514-0.

13.

Angiotensin-converting enzyme inhibitor usage and acute kidney injury: a secondary analysis of RENAL study outcomes.

Wang AY, Bellomo R, Ninomiya T, Lo S, Cass A, Jardine M, Gallagher M; RENAL Study Investigators; ANZICS Clinical Trials Group.

Nephrology (Carlton). 2014 Oct;19(10):617-22. doi: 10.1111/nep.12284.

PMID:
24894685
14.

Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.

Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansdell D, McIntyre L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Khwaja K, Sheppard JA, Warkentin TE; PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group.

J Crit Care. 2014 Jun;29(3):470.e7-15. doi: 10.1016/j.jcrc.2014.02.004. Epub 2014 Feb 14.

PMID:
24726205
15.

Calorie intake and patient outcomes in severe acute kidney injury: findings from The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study trial.

Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C; RENAL Study Investigators, Su S.

Crit Care. 2014 Mar 14;18(2):R45. doi: 10.1186/cc13767.

16.

Long-term survival and dialysis dependency following acute kidney injury in intensive care: extended follow-up of a randomized controlled trial.

Gallagher M, Cass A, Bellomo R, Finfer S, Gattas D, Lee J, Lo S, McGuinness S, Myburgh J, Parke R, Rajbhandari D; POST-RENAL Study Investigators and the ANZICS Clinical Trials Group.

PLoS Med. 2014 Feb 11;11(2):e1001601. doi: 10.1371/journal.pmed.1001601. eCollection 2014 Feb.

17.

Sodium administration in critically ill patients in Australia and New Zealand: a multicentre point prevalence study.

Bihari S, Peake SL, Seppelt I, Williams P, Bersten A; George Institute for Global Health; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2013 Dec;15(4):294-300.

PMID:
24289511
18.

Targeted temperature management at 33°C versus 36°C after cardiac arrest.

Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Åneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Køber L, Langørgen J, Lilja G, Møller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H; TTM Trial Investigators.

N Engl J Med. 2013 Dec 5;369(23):2197-206. doi: 10.1056/NEJMoa1310519. Epub 2013 Nov 17.

19.

Intestinal parasitosis in school children of Lalitpur district of Nepal.

Tandukar S, Ansari S, Adhikari N, Shrestha A, Gautam J, Sharma B, Rajbhandari D, Gautam S, Nepal HP, Sherchand JB.

BMC Res Notes. 2013 Nov 9;6:449. doi: 10.1186/1756-0500-6-449.

20.

Australasian Resuscitation In Sepsis Evaluation trial statistical analysis plan.

Delaney A, Peake SL, Bellomo R, Cameron P, Holdgate A, Howe B, Higgins A, Presneill J, Webb S; ARISE Investigators.

Emerg Med Australas. 2013 Oct;25(5):406-15. doi: 10.1111/1742-6723.12116. Epub 2013 Sep 9.

PMID:
24099368

Supplemental Content

Loading ...
Support Center